ArticleHematology, transfusion and cell therapy2026
Genetic diversity of the RHD gene in blood donors from the Brazilian Central-West.
Article in Hematology, transfusion and cell therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe Rh blood group system is recognized for its complexity and its clinical importance in transfusion medicine. Antibodies against Rh antigens are associated with hemolytic transfusion reactions, autoimmune hemolytic anemia, and hemolytic disease of the fetus and newborn. The present study aims to characterize D antigens and assess their allele frequencies at the molecular level.
methodsMolecular characterization of RHD variants was performed on blood donors from the Brazilian Central-West who presented atypical D typing results. Serological profiles of all identified RHD variant alleles were also analyzed using different anti-D clones.
resultsAmong the D-positive samples, 1.25% exhibited weak or discrepant agglutination during serological D typing. Most samples (67/103; 65%) were classified within the RHD*weak partial 4 cluster, followed by RHD*weak D type 3 (17/103; 16%). Lower frequencies were observed for RHD*weak D type 1 (2/103; 1.9%) and RHD*weak D type 2 (6/103; 5.8%). Furthermore, the rare RHD*weak D type 38 and RHD*weak D type 145 variants were identified. Analysis with different anti-D reagents showed that 52% of the samples had agglutination scores below 2+. Notably, 27% were classified as inconclusive, and 21% exhibited RhD serological discrepancies.
conclusionAtypical reactions in RhD serological testing indicate the presence of variant D antigens. The RHD*weak partial 4 allele was the most prevalent RHD variant in the Brazilian Central-West population. However, the identification of rare RHD*weak D variants, such as types 38 and 145, highlight the genetic diversity reflective of the region's multiracial composition. Understanding the distribution of RHD variants can improve transfusion support and inform future RHD genotyping strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.